[Managing patients with therapeutic antibodies in odontostomatology].

Abstract : Immunotherapies, particularly therapeutic antibodies, are increasingly used in the treatment of many autoimmune or oncological diseases. Patients treated with therapeutic antibodies may present with an increased risk of infection or of osteonecrosis of the jaws (ONJ). There is currently no consensus on the management of patients treated with therapeutic antibodies. These treatments are mainly used in hospitals, but they have been increasingly prescribed in ambulatory treatment for patients undergoing oral care. It is therefore important to establish therapeutic precautions for these patients. We had for aim to describe these antibody therapies, their indications, their potentially adverse effects in the oral cavity and to review the latest recommendations.
Type de document :
Article dans une revue
Rev Stomatol Chir Maxillofac Chir Orale, 2014, 115 (3), pp.152-63. 〈10.1016/j.revsto.2014.03.004〉
Liste complète des métadonnées

Contributeur : Geneviève Michel <>
Soumis le : mardi 24 juin 2014 - 11:48:34
Dernière modification le : vendredi 31 août 2018 - 13:59:39




J. Demoersman, A. Soueidan, P. Corre, Jacque-Olivier Pers. [Managing patients with therapeutic antibodies in odontostomatology].. Rev Stomatol Chir Maxillofac Chir Orale, 2014, 115 (3), pp.152-63. 〈10.1016/j.revsto.2014.03.004〉. 〈hal-01011660〉



Consultations de la notice